$SGMO
SANGAMO THERAPEUTICS, INC

2015 Q1 Form 10-K Financial Statement

#000156459015000950 Filed on February 25, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2014
Revenue $13.49M $14.95M $45.87M
YoY Change 66.23% 117.67% 90.07%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.730M $4.330M $15.70M
YoY Change 29.95% 5.35% 14.6%
% of Gross Profit
Research & Development $14.98M $14.99M $56.97M
YoY Change 23.98% 39.05% 53.82%
% of Gross Profit
Depreciation & Amortization $147.0K $100.0K $549.0K
YoY Change 19.51% -50.0% -3.51%
% of Gross Profit
Operating Expenses $19.71M $19.42M $72.65M
YoY Change 25.34% 29.1% 42.9%
Operating Profit -$6.221M -$26.78M
YoY Change -18.26% 0.28%
Interest Expense $150.0K $150.0K $400.0K
YoY Change 275.0% 400.0% 300.0%
% of Operating Profit
Other Income/Expense, Net $364.0K
YoY Change 343.9%
Pretax Income -$6.067M -$4.320M -$26.42M
YoY Change -19.88% -46.93% -0.78%
Income Tax -$748.0K $0.00
% Of Pretax Income
Net Earnings -$5.319M -$4.319M -$26.42M
YoY Change -29.75% -46.97% -0.78%
Net Earnings / Revenue -39.43% -28.89% -57.59%
Basic Earnings Per Share
Diluted Earnings Per Share -$76.79K -$62.96K -$394.0K
COMMON SHARES
Basic Shares Outstanding 69.17M 68.40M
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q4 2014
SHORT-TERM ASSETS
Cash & Short-Term Investments $225.7M $226.2M $179.0M
YoY Change 5.78% 63.44% 92.89%
Cash & Equivalents $25.26M $6.030M $6.000M
Short-Term Investments $200.5M $220.2M $172.9M
Other Short-Term Assets $1.000M $183.0K $1.100M
YoY Change 186.53% -4.19% 10.0%
Inventory
Prepaid Expenses $623.0K
Receivables $6.600M $10.37M $10.40M
Other Receivables $400.0K $400.0K $400.0K
Total Short-Term Assets $203.9M $190.9M $190.9M
YoY Change -7.41% 96.23% 96.2%
LONG-TERM ASSETS
Property, Plant & Equipment $3.000M $1.479M $1.500M
YoY Change 112.77% 5.19% 7.14%
Goodwill $1.585M $1.585M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $29.80M $47.30M $47.30M
YoY Change -1.97% 22.22% 22.22%
Other Assets $157.0K $139.0K $100.0K
YoY Change 247.5%
Total Long-Term Assets $34.61M $52.33M $52.30M
YoY Change -1.94% 20.13% 20.23%
TOTAL ASSETS
Total Short-Term Assets $203.9M $190.9M $190.9M
Total Long-Term Assets $34.61M $52.33M $52.30M
Total Assets $238.5M $243.2M $243.2M
YoY Change -6.65% 72.69% 72.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.800M $5.525M $5.500M
YoY Change 11.48% 82.83% 83.33%
Accrued Expenses $1.700M $3.400M $5.800M
YoY Change 13.33% -8.11% 31.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.97M $20.88M $20.90M
YoY Change 21.71% 106.12% 106.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.00M $14.90M $14.90M
YoY Change -47.37% 81.71% 81.71%
Total Long-Term Liabilities $11.00M $14.90M $14.90M
YoY Change -47.37% 81.71% 81.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.97M $20.88M $20.90M
Total Long-Term Liabilities $11.00M $14.90M $14.90M
Total Liabilities $31.02M $36.58M $36.60M
YoY Change -18.54% 91.23% 91.62%
SHAREHOLDERS EQUITY
Retained Earnings -$333.9M -$328.6M
YoY Change 7.8% 8.74%
Common Stock $541.3M $535.2M
YoY Change 79742.48% 26.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $207.5M $206.6M $206.6M
YoY Change
Total Liabilities & Shareholders Equity $238.5M $243.2M $243.2M
YoY Change -6.65% 72.69% 72.73%

Cashflow Statement

Concept 2015 Q1 2014 Q4 2014
OPERATING ACTIVITIES
Net Income -$5.319M -$4.319M -$26.42M
YoY Change -29.75% -46.97% -0.78%
Depreciation, Depletion And Amortization $147.0K $100.0K $549.0K
YoY Change 19.51% -50.0% -3.51%
Cash From Operating Activities -$2.400M -$2.700M -$5.700M
YoY Change -121.09% 58.82% -70.74%
INVESTING ACTIVITIES
Capital Expenditures $1.084M $0.00 $621.0K
YoY Change 760.32% 43.75%
Acquisitions $621.0K
YoY Change -886.08%
Other Investing Activities $19.50M -$200.0K -$100.0M
YoY Change 387.5% -99.71% 47.71%
Cash From Investing Activities $18.40M -$400.0K -$100.7M
YoY Change 373.37% -99.42% 47.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.178M $12.94M
YoY Change -58.1% 49.91%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.200M -2.100M 102.2M
YoY Change -96.84% -520.0% 34.28%
NET CHANGE
Cash From Operating Activities -2.400M -2.700M -5.700M
Cash From Investing Activities 18.40M -400.0K -100.7M
Cash From Financing Activities 3.200M -2.100M 102.2M
Net Change In Cash 19.20M -5.200M -4.200M
YoY Change -83.54% -92.58% -63.46%
FREE CASH FLOW
Cash From Operating Activities -$2.400M -$2.700M -$5.700M
Capital Expenditures $1.084M $0.00 $621.0K
Free Cash Flow -$3.484M -$2.700M -$6.321M
YoY Change -130.96% 58.82% -68.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-37000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26454000
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67022000
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q4 us-gaap Assets Current
AssetsCurrent
190879000
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014Q4 us-gaap Assets
Assets
243212000
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8704000
CY2014Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2853000
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2013Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
82627000
CY2013Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
338000
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69170150
CY2014Q2 dei Entity Public Float
EntityPublicFloat
800449430
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6030000
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
172932000
CY2014Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
423000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10368000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3155000
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
320000
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
457000
CY2014 dei Trading Symbol
TradingSymbol
SGMO
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10186000
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
623000
CY2014 dei Entity Registrant Name
EntityRegistrantName
SANGAMO BIOSCIENCES INC
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001001233
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-26624000
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55974000
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52741000
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14000
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22250000
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26638000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-26417000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-22264000
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31709000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15677000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13800000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12144000
CY2014 us-gaap Operating Expenses
OperatingExpenses
72651000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
140838000
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
160000000
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
69062394
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62243892
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69062394
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62243892
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
56744000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36979000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-26781000
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
320000
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
183000
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
191000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
97274000
CY2014Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
47260000
CY2013Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
38663000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1479000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1406000
CY2014Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1870000
CY2013Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1870000
CY2014Q4 us-gaap Goodwill
Goodwill
1585000
CY2013Q4 us-gaap Goodwill
Goodwill
1585000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
139000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
40000
CY2013Q4 us-gaap Assets
Assets
140838000
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4380000
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3194000
CY2014Q4 sgmo Escrow Liability
EscrowLiability
275000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9200000
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2750000
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
153000
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
59000
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
227000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4156000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-22198000
CY2014 us-gaap Revenue From Grants
RevenueFromGrants
1990000
CY2014 us-gaap Revenues
Revenues
45870000
CY2013 us-gaap Revenues
Revenues
24133000
CY2013 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
60000
CY2013 us-gaap Operating Expenses
OperatingExpenses
50839000
CY2012 us-gaap Operating Expenses
OperatingExpenses
43853000
CY2013Q4 sgmo Escrow Liability
EscrowLiability
275000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16766000
CY2013 sgmo Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Value Of Common Stock Issued
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueOfCommonStockIssued
1200000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9050000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2282000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20882000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10131000
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
13149000
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
6679000
CY2014Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1800000
CY2013Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1570000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
748000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
748000
CY2014Q4 us-gaap Liabilities
Liabilities
36579000
CY2013Q4 us-gaap Liabilities
Liabilities
19128000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
690000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
622000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
534518000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
423209000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-328550000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-302133000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
206633000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
121710000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
243212000
CY2014 sgmo Collaboration Agreements
CollaborationAgreements
43880000
CY2013 sgmo Collaboration Agreements
CollaborationAgreements
21678000
CY2012 sgmo Collaboration Agreements
CollaborationAgreements
18186000
CY2013 us-gaap Revenue From Grants
RevenueFromGrants
2455000
CY2012 us-gaap Revenue From Grants
RevenueFromGrants
3469000
CY2012 us-gaap Revenues
Revenues
21655000
CY2014 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
230000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-26706000
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
364000
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
82000
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-66000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
80132000
CY2012 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1219000
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
457000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5338000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
64896000
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
69492000
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6118000
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
496000
CY2013 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1200000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6146000
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
93796000
CY2014 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7533000
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
848000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9200000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
549000
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
569000
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
660000
CY2014 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1098000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12937000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11493000
CY2014 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4556000
CY2013 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2015000
CY2013 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-912000
CY2012 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-889000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
9200000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
6146000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
5338000
CY2012 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-123000
CY2013 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
320000
CY2013 sgmo Increase Decrease In Escrow Liabilities
IncreaseDecreaseInEscrowLiabilities
275000
CY2014 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
85000
CY2013 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
148000
CY2012 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-141000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7213000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1008000
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3414000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
258000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
160000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-14000
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4324000
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
269000
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1503000
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-341000
CY2013 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
721000
CY2012 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
800000
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
13238000
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2190000
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
11134000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5675000
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-19482000
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8082000
CY2014 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
227802000
CY2013 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
118894000
CY2012 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
91428000
CY2014 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
127765000
CY2013 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
51129000
CY2012 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
103470000
CY2013 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-79000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
621000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
432000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
723000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-100658000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-68118000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
11319000
CY2014 sgmo Net Proceeds From Issuance Public Offering
NetProceedsFromIssuancePublicOffering
93796000
CY2013 sgmo Net Proceeds From Issuance Public Offering
NetProceedsFromIssuancePublicOffering
69492000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8630000
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1676000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
102177000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
76107000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1676000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4913000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21679000
CY2014 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y15D
CY2014 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2014 sgmo Cash Equivalent Maturity Period Highly Liquid Investment
CashEquivalentMaturityPeriodHighlyLiquidInvestment
three months or less
CY2014 sgmo Minimum Percentage Of Likelihood Of Indefinite Lived Intangible Assets Being Impaired
MinimumPercentageOfLikelihoodOfIndefiniteLivedIntangibleAssetsBeingImpaired
0.50
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8006380
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8405864
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9184346
CY2014 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2014Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
3182000
CY2014Q4 us-gaap Marketable Securities
MarketableSecurities
220192000
CY2014Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
223374000
CY2014Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1800000
CY2013Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
6934000
CY2013Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
128224000
CY2013Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1570000
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1570000
CY2014 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
230000
CY2014Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1800000
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
223399000
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
128212000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
33000
CY2013Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
12000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
58000
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
223374000
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
128224000
CY2014 sgmo Investments Maturity Dates Available For Sale Securities
InvestmentsMaturityDatesAvailableForSaleSecurities
P2Y
CY2014 sgmo Available For Sale Securities Maturity Percentage Next Twelve Months
AvailableForSaleSecuritiesMaturityPercentageNextTwelveMonths
0.79
CY2014 sgmo Available For Sale Securities Maturity Percentage In Next Twelve Months And Year Two
AvailableForSaleSecuritiesMaturityPercentageInNextTwelveMonthsAndYearTwo
0.21
CY2014 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2013 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2012 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2014 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2013 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2012 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6146000
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5338000
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
17200000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.16
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.29
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.76
CY2014 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
107203
CY2013 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
180551
CY2012 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
175375
CY2014 sgmo Stock Issued Under Employee Stock Purchase Plans Average Exercise Price
StockIssuedUnderEmployeeStockPurchasePlansAverageExercisePrice
7.92
CY2013 sgmo Stock Issued Under Employee Stock Purchase Plans Average Exercise Price
StockIssuedUnderEmployeeStockPurchasePlansAverageExercisePrice
2.75
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
20400000
CY2014 sgmo Employee Stock Purchase Plan Rights Weighted Average Estimated Fair Value
EmployeeStockPurchasePlanRightsWeightedAverageEstimatedFairValue
3.25
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8900000
CY2012 sgmo Stock Issued Under Employee Stock Purchase Plans Average Exercise Price
StockIssuedUnderEmployeeStockPurchasePlansAverageExercisePrice
2.61
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
600000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
49400000
CY2013 sgmo Employee Stock Purchase Plan Rights Weighted Average Estimated Fair Value
EmployeeStockPurchasePlanRightsWeightedAverageEstimatedFairValue
1.47
CY2012 sgmo Employee Stock Purchase Plan Rights Weighted Average Estimated Fair Value
EmployeeStockPurchasePlanRightsWeightedAverageEstimatedFairValue
2.51
CY2014Q1 sgmo Number Of Companies Jointly Conducting Research Program
NumberOfCompaniesJointlyConductingResearchProgram
2
CY2014Q1 sgmo Number Of Research Program
NumberOfResearchProgram
2
CY2014 sgmo Potential Royalty Payments To Entity
PotentialRoyaltyPaymentsToEntity
Two times the amount Sangamo receives in funding under the agreement.
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5378000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4927000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3899000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3521000
CY2012 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
500000
CY2012 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment
400000
CY2014 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
100000
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
700000
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
700000
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
600000
CY2014 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2018-01-31
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
865000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
901000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
928000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
748000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
496000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3938000
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2014 sgmo Specified Stockholder Ownership Percentage
SpecifiedStockholderOwnershipPercentage
0.10
CY2014 sgmo Share Based Compensation Arrangement By Share Based Payment Award Purchase Price Of Common Stock Percent For Specified Stockholder
ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockPercentForSpecifiedStockholder
1.10
CY2014 sgmo Share Based Compensation Arrangement By Share Based Payment Award Options Maximum Term For Specified Stock Holder
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTermForSpecifiedStockHolder
P5Y
CY2014Q4 sgmo Common Stock Exchange Ratio
CommonStockExchangeRatio
1
CY2014 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.33
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1694400
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1959201
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
134683
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7526430
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4929932
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.20
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.19
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.17
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.77
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.90
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
8.67
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.21
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M13D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y5M9D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y26D
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
50766000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
49437000
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
39475000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
54900000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
8500000
CY2014Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
8006380
CY2014 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y7M13D
CY2014Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
4929932
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5525000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3022000
CY2014Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
7.21
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
9100000
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
4100000
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
100000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1063657
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
488000
CY2014 sgmo Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod
616756
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
35499
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
899402
CY2014Q4 sgmo Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingNumber
754931
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y7M10D
CY2014 sgmo Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestWeightedAverageRemainingContractualTerm
P1Y6M18D
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
13680000
CY2014Q4 sgmo Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestAggregateIntrinsicValue
11482000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
90921000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
81944000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
8646000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
7996000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
8171000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7927000
CY2014Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
2690000
CY2013Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
3563000
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2471000
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1677000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
112899000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
103107000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
112899000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
103107000
CY2014Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
748000
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
748000
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
9800000
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
14900000
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5400000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
330900000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
278100000
CY2014Q4 sgmo Deferred Tax Assets Tax Credit Carryforwards Research Federal
DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal
6700000
CY2014Q4 sgmo Deferred Tax Assets Tax Credit Carryforwards Research State And Local
DeferredTaxAssetsTaxCreditCarryforwardsResearchStateAndLocal
7000000
CY2014 sgmo Federal Research Tax Credit Carryforward Expiration Year
FederalResearchTaxCreditCarryforwardExpirationYear
2018
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3182000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
228000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
28000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3438000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2735000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
294000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
153000
CY2014Q4 sgmo Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
2435000
CY2013Q4 sgmo Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
727000
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
531000
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
510000
CY2014Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
129000
CY2013Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
121000
CY2014Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
84000
CY2014 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.50
CY2014Q4 sgmo Employers Matching Contribution Percentage Towards Employees Contribution
EmployersMatchingContributionPercentageTowardsEmployeesContribution
0.06
CY2014 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
2000
CY2013 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
1500
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
200000
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000
CY2014Q1 us-gaap Revenues
Revenues
8116000
CY2014Q2 us-gaap Revenues
Revenues
10385000
CY2014Q3 us-gaap Revenues
Revenues
12417000
CY2014Q4 us-gaap Revenues
Revenues
14952000
CY2013Q1 us-gaap Revenues
Revenues
4623000
CY2013Q2 us-gaap Revenues
Revenues
6934000
CY2013Q3 us-gaap Revenues
Revenues
5707000
CY2013Q4 us-gaap Revenues
Revenues
6869000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
15727000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
17432000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
20071000
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
19421000
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
11528000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
12402000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
11866000
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
15043000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-7572000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-6981000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-7545000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-4319000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-6885000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-5450000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-6145000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-8144000
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13

Files In Submission

Name View Source Status
0001564590-15-000950-index-headers.html Edgar Link pending
0001564590-15-000950-index.html Edgar Link pending
0001564590-15-000950.txt Edgar Link pending
0001564590-15-000950-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g20150225204222125314.jpg Edgar Link pending
g20150225204222234315.jpg Edgar Link pending
g20150225204222391316.jpg Edgar Link pending
g20150225204222641317.jpg Edgar Link pending
g20150225204229985318.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sgmo-10k_20141231.htm Edgar Link pending
sgmo-20141231.xml Edgar Link completed
sgmo-20141231.xsd Edgar Link pending
sgmo-20141231_cal.xml Edgar Link unprocessable
sgmo-20141231_def.xml Edgar Link unprocessable
sgmo-20141231_lab.xml Edgar Link unprocessable
sgmo-20141231_pre.xml Edgar Link unprocessable
sgmo-ex211_201412316.htm Edgar Link pending
sgmo-ex231_201412317.htm Edgar Link pending
sgmo-ex311_201412318.htm Edgar Link pending
sgmo-ex312_201412319.htm Edgar Link pending
sgmo-ex321_2014123110.htm Edgar Link pending
Show.js Edgar Link pending